Wilmington-based Pharmaceutical Product Development announced recently that PPD Laboratories has been recognized as a 2018 top innovator in drug development by CenterWatch, a publisher of clinical trials information for clinical research professionals.
 
PPD’s Preclarus investigator site portal and companion mobile application were acknowledged for industry leadership.
 
A fully integrated component of PPD – a leading global contract research organization – PPD Laboratories offers a comprehensive set of laboratory services in the industry, spanning bioanalytical, biomarkers, central lab, GMP and vaccine sciences, the release stated.
 
“As is evident with the Preclarus investigator site portal, we are focused on fostering an environment that promotes and uses innovation to provide efficiencies, advancements and differentiation that help our customers deliver life-changing therapies,” Christopher Fikry, executive vice president of PPD Laboratories, said in the news release.
 
The Preclarus portal is a webbased platform, accessible via standard web browsers, that streamlines site activities associated with clinical trials, such as subject registration, sample accessioning, test result reporting and critical value alerts.
 
The portal uses barcode scanning technology to register a sample immediately after an investigator site receives it from a patient. This process inserts the sample’s information directly into PPD Laboratories’ global database in real time, alerting the lab, clients and other stakeholders.
 
The portal’s real-time feedback has resulted in a 67 percent reduction in exceptions and queries sites traditionally experience that can adversely impact the length of the drug development process, the release stated.
 
In 2018, to further support the schedules and workflows of research professionals at investigator sites, PPD Laboratories will extend the functionality of the online Preclarus investigator site portal to a mobile application.